Dementia/Alzheimer Disease
RSSArticles
-
Nutritional Interventions for Prodromal Alzheimer’s Disease
Over a 36-month period, patients with prodromal Alzheimer’s disease who consumed Fortasyn Connect (Souvenaid), a nutraceutical drink, demonstrated a slower decline in cognitive functions vs. the control group.
-
National Alzheimer’s Plan Updated with New Focus on Healthy Aging
Feds add sixth goal in the ninth version of this annually released report.
-
Drinking More Coffee May Protect Against Cognitive Decline
Among adults older than age 60 years, heavier coffee consumption was associated with slower cognitive decline in executive function and less beta-amyloid accumulation.
-
Researchers Can Remove Recruitment Barriers in Alzheimer’s Trials
What can be consolidated, made simpler, or translated? What data can be collected outside your research setting? How can you communicate better with prospective and current research participants?
-
Tailoring Dietary Recommendations to Protect Cognitive Health
Preventing inflammation as patients age is becoming key focus of lowering dementia risk.
-
AAN Offers Ethical Guidance on Alzheimer’s Drug
Neurology experts issue caution on costs, side effects regarding the approved-but-controversial Aduhelm.
-
Ethics of 10-Year Research Agenda for Dementia, Alzheimer’s Studies
There is a pressing need for more research on non-cure-based treatments for people living with dementia. That gap in is a real ethical concern. Social-behavioral research can help family members who are struggling to figure out where the loved one with dementia is going to live.
-
Functional Cognitive Disorder: An Important Condition to Recognize
Functional cognitive disorder (FCD) can describe cognitive difficulties that are present where there is no biologic cause, but a lack of consensus in diagnostic criteria limits its use in clinical practice and research. The authors proposed an operational definition for FCD as the cognitive phenotype of functional neurological disorder.
-
Statins, Cognitive Decline, and Dementia
An analysis of the ASPREE database showed that with almost five years of follow-up, statins are not associated with cognitive decline or dementia in a large group of elderly subjects in whom multiple tests of cognition were performed serially.
-
Researchers Find Lower Amyloid Levels in Patients on Blood Sugar Control Drug
An investigation reveals an interesting trait among those taking a common diabetes management solution.